Blackstone Group Inc

$ 124.15

0.44%

21 Jul - close price

  • Market Cap 151,083,811,000 USD
  • Current Price $ 124.15
  • High / Low $ 125.20 / 123.15
  • Stock P/E 32.61
  • Book Value 10.66
  • EPS 3.79
  • Next Earning Report 2026-07-23
  • Dividend Per Share $4.97
  • Dividend Yield 3.92 %
  • Next Dividend Date -
  • ROA 0.13 %
  • ROE 0.30 %
  • 52 Week High 184.54
  • 52 Week Low 100.80

About

Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.

Analyst Target Price

$139.95

Quarterly Earnings

Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Reported Date 2026-04-232026-01-292025-10-232025-07-242025-04-172025-01-302024-10-172024-07-182024-04-182024-01-252023-10-192023-07-20
Reported EPS 1.361.751.521.211.091.691.010.960.981.110.940.93
Estimated EPS 1.341.531.231.091.061.470.910.980.970.951.010.92
Surprise 0.020.220.290.120.030.220.1-0.020.010.16-0.070.01
Surprise Percentage 1.4925%14.3791%23.5772%11.0092%2.8302%14.966%10.989%-2.0408%1.0309%16.8421%-6.9307%1.087%

Next Quarterly Earnings

Jun 2026
Reported Date 2026-07-23
Fiscal Date Ending 2026-06-30
Estimated EPS 1.32
Currency USD

Previous Dividend Records

May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024Aug 2024May 2024Feb 2024
Payment Date 2026-05-112026-02-172025-11-102025-08-112025-05-052025-02-182024-11-042024-08-052024-05-062024-02-12
Amount $1.16$1.49$1.29$1.03$0.93$1.44$0.86$0.82$0.83$0.94

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: BX

...
TXNM, Blackstone Push Out Sale Completion Deadline

2026-07-21 19:45:16

TXNM Energy Inc. and Blackstone Infrastructure have extended their deadline for Blackstone's $11.5 billion acquisition of TXNM, the parent company of PNM and TNMP, to May 31 of next year. This extension comes after New Mexico regulators voided a $400 million stock sale related to the deal due to violations of state law, necessitating a reversal through a loan from Wells Fargo Bank. Both companies remain committed to the partnership, stating it is crucial for providing clean, affordable, and reliable power and will strengthen the grid and long-term investment in New Mexico and Texas.

...
MaxCyte Grants Roche Cell Therapy Tech License

2026-07-21 18:40:23

MaxCyte has granted Genentech, a member of the Roche Group, a multi-platform technology license for its cell-engineering technologies. This agreement provides Genentech with non-exclusive access to MaxCyte's ExPERT GTx platform and other technologies for use across multiple research, clinical development, and manufacturing programs. The financial terms and specific programs were not disclosed, but the deal strengthens Genentech's cell therapy manufacturing capabilities and expands MaxCyte's pharmaceutical customer base.

...
TKO Miller Advises CD Energy Services, a Portfolio Company of Briarwood Partners, on its Sale to ConTeras Industrial Group, a Portfolio Company of Funds Managed by Oaktree Capital Management

2026-07-21 18:09:31

TKO Miller announced that CD Energy Services, a specialty services provider and a portfolio company of Briarwood Partners, has been acquired by ConTeras Industrial Group. This acquisition significantly enhances ConTeras' specialty service capabilities in the Western U.S. and expands its support for industrial maintenance, turnaround, and capital projects. TKO Miller served as the exclusive investment banking advisor to CD Energy Services during the transaction.

...
Vornado Realty Trust (NYSE:VNO) Given New $42.00 Price Target at Piper Sandler

2026-07-21 17:41:45

Piper Sandler has increased its price target for Vornado Realty Trust (NYSE:VNO) from $28.00 to $42.00, maintaining a "neutral" rating. This adjustment follows Vornado's recent quarterly earnings, which missed EPS estimates but exceeded revenue expectations, and the authorization of a $300 million share buyback program. The stock currently holds an average "Hold" rating from analysts with an average target price of $38.67.

...
Catalyst Pharmaceuticals (NASDAQ:CPRX) departs Nasdaq as merger spread narrows to one cent

2026-07-21 14:41:15

Catalyst Pharmaceuticals has been delisted from Nasdaq after its acquisition by Angelini Pharma was finalized on July 15, with each share exchanged for $31.50 in cash. The merger spread narrowed to just one cent by the final trading day, though a significant portion of the takeover gains had already been accounted for in the stock price before the official announcement. The article also notes Catalyst's financial performance prior to the sale, including a 5.6% increase in Q1 revenue.

...
Growth in AUM Balance Likely to Support Ameriprise's Q2 Earnings

2026-07-21 14:37:10

Ameriprise Financial, Inc. (AMP) is expected to report increased revenues and higher assets under management (AUM) and assets under administration (AUA) balances for its second quarter of 2026 earnings, scheduled for July 23. While management and financial advice fees, distribution fees, and other revenues are projected to grow, net investment income might decline. Despite higher overall costs due to technology upgrades and hirings, the company's continuous focus on cost management and decent inflows are likely to support its earnings results.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi